|
1.
|
|
5 p, 310.2 KB |
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols
/
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Morgades, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Montesinos, Pau (Hospital Universitari i Politècnic La Fe de València) ;
Gonzalez-Campos, Jose (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Torrent Catarineu, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gil, Cristina (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Bernal, Teresa (Hospital Universitario Central de Asturias) ;
Tormo, Mar (Hospital Clínic Universitari (València)) ;
Mercadal, Santiago (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Novoa, Sandra (Hospital Universitari Vall d'Hebron) ;
Garcia Cadenas, Irene (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Queipo de Llano, M. Paz (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Cervera, Marta (Hospital Universitari Joan XXIII de Tarragona) ;
Coll, Rosa (Hospital Universitari de Girona Doctor Josep Trueta) ;
Bermúdez, Arancha (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Amigo, María-Luz (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Monsalvo, Silvia (Hospital General Universitario Gregorio Marañón) ;
Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ;
Garcia-Boyero, Raimundo (Hospital General Universitari de Castelló) ;
Novo, Andres (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Hernandez Rivas, Jesús Maria (Hospital Universitario de Salamanca) ;
Cladera, Antonia (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Martinez-Sanchez, Pilar (Hospital Universitario 12 de Octubre (Madrid)) ;
Serrano, Josefina (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Artola, Maria Teresa (Donostia Unibertsitate Ospitalea) ;
Soria, Beatriz (Hospital Universitario de Canarias (La Laguna)) ;
Abella Monreal, Eugenia (Hospital del Mar (Barcelona, Catalunya)) ;
Vall-Llovera, Ferran (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Bergua Burgues, Juan Miguel (Hospital San Pedro de Alcántara) ;
Herrera, Pilar (Hospital Universitario Ramón y Cajal (Madrid)) ;
Barrios, Daniel (Hospital Regional Universitario de Málaga) ;
Ribera, Jose-Maria (Universitat Autònoma de Barcelona. Departament de Medicina)
2022 -  10.1097/HS9.0000000000000810
HemaSphere, Vol. 7 (december 2022)
|
|
|
2.
|
|
20 p, 525.5 KB |
Managing hematological cancer patients during the COVID-19 pandemic : an ESMO-EHA Interdisciplinary Expert Consensus
/
Buske, C. (University Hospital of Ulm (Alemanya)) ;
Dreyling, M. (Department of Medicine III at LMU Hospital) ;
Álvarez Larrán, Alberto (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Apperley, Jane (Imperial College London) ;
Arcaini, Luca (University of Pavia) ;
Besson, Caroline (UVSQ. Inserm. CESP) ;
Bullinger, Lars (Charité - Universitätsmedizin Berlin) ;
Corradini, Paolo (University of Milan) ;
Della Porta, Matteo Giovanni (Humanitas University) ;
Dimopoulos, Meletios (National and Kapodistrian University of Athens) ;
D'Sa, Shirley (University College London Hospitals NHS Foundation Trust) ;
Eich, H.T. (University of Muenster) ;
Foà, R. (Sapienza University) ;
Ghia, P. (Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele) ;
da Silva, M.G. (Portuguese Institute of Oncology) ;
Gribben, J. (Queen Mary University of London) ;
Hajek, Roman (University of Ostrava) ;
Harrison, C. (Guy's and St Thomas' NHS Foundation Trust) ;
Heuser, M. (Hannover Medical School) ;
Kiesewetter, Barbara (Medical University of Vienna) ;
Kiladjian, Jean-Jacques (Université de Paris) ;
Kroeger, Nicolaus (University Hospital Hamburg-Eppendorf) ;
Moreau, Philippe (University Hospital Hotel-Dieu) ;
Passweg, Jakob R. (Basel University Hospital) ;
Peyvandi, F. (University of Milan) ;
Rea, Delphine (Hôpital Saint-Louis) ;
Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Robak, Tadeusz (Medical University of Lodz) ;
San-Miguel, J (Clínica Universidad de Navarra) ;
Santini, V. (University of Florence) ;
Sanz, G. (CIBERONC. IS Carlos III) ;
Sonneveld, P. (Erasmus MC Cancer Institute) ;
Von Lilienfeld-Toal, M. (Hans Knöll Institute) ;
Wendtner, Clemens-Martin (Ludwig-Maximilian University) ;
Pentheroudakis, G. (European Society for Medical Oncology) ;
Passamonti, Francesco (University of Insubria)
Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. [...]
2022 - 10.1016/j.esmoop.2022.100403
ESMO open, Vol. 7 Núm. 2 (april 2022) , p. 100403
|
|
|
3.
|
|
7 p, 1.3 MB |
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
/
Genescà, Eulàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Morgades, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
González-Gil, Celia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Fuster-Tormo, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Haferlach, Claudia (MLL Munich Leukemia Laboratory) ;
Meggendorfer, Manja (MLL Munich Leukemia Laboratory) ;
Montesinos, Pau (Hospital Universitari Politècnic La Fe & CIBERONC. Instituto Carlos III) ;
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Gil, Cristina (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Coll, Rosa (Hospital Universitari de Girona Doctor Josep Trueta) ;
Moreno, María-José (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Martínez-Carballeira, Daniel (Hospital Universitario Central de Asturias) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Vives Polo, Susana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ribera, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
González-Campos, José (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Díaz-Beyá, Marina (Hospital Clínic i Provincial de Barcelona) ;
Mercadal, Santiago (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Artola, María-Teresa (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Cladera, Antonia (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Tormo, Mar (Hospital Clínic Universitari (València)) ;
Bermúdez, Arancha (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Vall-Llovera, Ferran (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Martínez-Sánchez, Pilar (Hospital Universitario 12 de Octubre (Madrid)) ;
Amigo, María-Luz (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Monsalvo, Silvia (Hospital Gregorio Marañón (Madrid)) ;
Novo, Andrés (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Cervera, Marta (Hospital Universitari Joan XXIII de Tarragona) ;
García-Guiñon, Antonio (Hospital Arnau de Vilanova (València)) ;
Ciudad Pizarro, Juana (Instituto de Investigación Biomédica de Salamanca) ;
Cervera, José (Hospital Universitari Politècnic La Fe & CIBERONC. Instituto Carlos III) ;
Hernández-Rivas, Jesús María (Hospital Clínico Universitario (Salamanca)) ;
Granada, Isabel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Haferlach, Torsten (MLL Munich Leukemia Laboratory) ;
Orfao, Alberto (Instituto de Investigación Biomédica de Salamanca) ;
Solé, Francesc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
The potential prognostic value of conventional karyotyping in adult T-cell acute lymphoblastic leukemia (T-ALL) remains an open question. We hypothesized that a modified cytogenetic classification, based on the number and type of cytogenetic abnormalities, would allow the identification of high-risk adult T-ALL patients. [...]
2021 - 10.1016/j.leukres.2021.106612
Leukemia Research, Vol. 109 (october 2021) , p. 106612
|
|
|
4.
|
|
8 p, 1009.5 KB |
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
/
Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
García-Calduch, Olga (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ribera, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Montesinos, Pau (Hospital Universitari i Politècnic La Fe de València) ;
Cano-Ferri, Isabel (Hospital Universitari i Politècnic La Fe de València) ;
Martínez, Pilar (Hospital Universitario 12 de Octubre (Madrid)) ;
Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ;
Esteban, Daniel (Hospital Clínic i Provincial de Barcelona) ;
García Fortes, María (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Alonso Vence, Natalia (Complejo Hospitalario Universitario de Santiago de Compostela) ;
González-Campos, José (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Bermúdez, Arancha (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Torrent Catarineu, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Genescà, Eulàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Mercadal, Santiago (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Martínez-Lopez, Joaquín (Hospital Doce De Octubre) ;
García-Sanz, Ramón (Hospital Universitario de Salamanca) ;
Universitat Autònoma de Barcelona
Promising results have been shown with the combination of ponatinib and chemotherapy in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). The PONALFIL (Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia) trial combined ponatinib (30 mg/d) with standard induction and consolidation chemotherapy followed by allogeneic hematopoietic stem cell transplant (alloHSCT) in newly diagnosed Ph + ALL patients aged 18 to 60 years. [...]
2022 - 10.1182/bloodadvances.2022007764
Blood advances, Vol. 6 (september 2022) , p. 5395-5402
|
|
|
5.
|
|
15 p, 1.3 MB |
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population : diagnostic and prognostic implications
/
Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Tapia, Gustavo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Muñoz-Marmol, Ana Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Muncunill Farreny, Josep (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
García, Olga (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Montoto, Silvia (Centre for Haemato-Oncology. Barts Cancer Institute. Queen Mary University of London) ;
Gribben, John G. (Centre for Haemato-Oncology. Barts Cancer Institute. Queen Mary University of London) ;
Calaminici, Maria (Centre for Haemato-Oncology. Barts Cancer Institute. Queen Mary University of London) ;
Martinez, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Veloza, Luis (Hospital Clínic i Provincial de Barcelona) ;
Martínez-Trillos, Alejandra (Hospital Clínic i Provincial de Barcelona) ;
Aldámiz-Echevarría, T (Hospital General Universitario Gregorio Marañón) ;
Menarguez, Javier (Hospital General Universitario Gregorio Marañón) ;
Terol, Maria José (Hospital Clínic Universitari (València)) ;
Ferrandez, Antonio (Hospital Clínic Universitari (València)) ;
Alcoceba, Miguel (Hospital Universitario de Salamanca) ;
Briones Meijide, Javier (Institut d'Investigació Biomèdica Sant Pau) ;
Gonzalez-Barca, Eva (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ;
Muntañola, Ana (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Moraleda, José Maria (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ;
Provencio, Mariano (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Abrisqueta, Pau (Hospital Universitari Vall d'Hebron) ;
Abella Monreal, Eugenia (Hospital del Mar (Barcelona, Catalunya)) ;
Colomo, Luis (Hospital del Mar (Barcelona, Catalunya)) ;
García-Ballesteros, Carlos (Department of Hematology. Hospital Arnau de Vilanova) ;
Garcia-Caro, Montserrat (Department of Hematology. Hospital de Mataro) ;
Sancho, Juan Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ribera, José Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Mate, José Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Navarro, José-Tomás (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
The frequency of aggressive subtypes of B-cell non-Hodgkin lymphoma (B-NHL), such as high-grade B-cell lymphomas (HGBL) with MYC and BCL2 and/or BCL6 rearrangement (HGBL-DH/TH) or Burkitt-like lymphoma (BL) with 11q aberration, is not well known in the HIV setting. [...]
2022 - 10.1111/his.14798
Histopathology, 2022
|
|
|
6.
|
|
6 p, 158.9 KB |
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols
/
Ribera Salas, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Granada, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Morgades, Mireia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
González, T. (Universidad de Salamanca) ;
Ciudad Pizarro, Juana (Centro de Investigación Biomédica en Red de Cáncer) ;
Such, Esperanza (Hospital Universitari i Politècnic La Fe de València) ;
Calasanz, M.J (Universidad de Navarra) ;
Mercadal, Santiago (Institut Català d'Oncologia) ;
Coll, Rosa (Hospital Universitari de Girona Doctor Josep Trueta) ;
González-Campos, José (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Tormo, M. (Hematology Department. Hospital Clínico Universitario) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Gil, C. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Cervera, Marta (Hospital Universitari Joan XXIII de Tarragona) ;
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Costa, D. (Hospital Clínic i Provincial de Barcelona) ;
Ayala, Rosa (Hospital Universitario 12 de Octubre (Madrid)) ;
Bermúdez, Arancha (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Orfao, Alberto (Centro de Investigación Biomédica en Red de Cáncer) ;
Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
The prognosis of t(1;19)(q23;p13)/transcription factor 3-pre-B-cell leukaemia homeobox 1 (TCF3-PBX1) in adolescent and adult patients with acute lymphoblastic leukaemia (ALL) treated with measurable residual disease (MRD)-oriented trials remains controversial. [...]
2021 - 10.1111/bjh.17844
British Journal of Haematology, 2021
|
|
|
7.
|
|
5 p, 740.1 KB |
COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA
/
PAGANO, Livio (Università Cattolica del Sacro Cuore) ;
SALMANTON-GARCÍA, Jon (University of Cologne) ;
MARCHESI, Francesco (IRCCS Regina Elena National Cancer Institute (Itàlia)) ;
LÓPEZ-GARCÍA, Alberto (Hospital Universitario Fundacion Jimenez Diaz (Madrid)) ;
Lamure, Sylvain (Universite de Montpellier) ;
ITRI, Federico (San Luigi Gonzaga Hospital) ;
GOMES-SILVA, Maria (Portuguese Institute of Oncology) ;
DRAGONETTI, Giulia (Università Cattolica del Sacro Cuore) ;
FALCES-ROMERO, Iker (Hospital Universitario La Paz (Madrid)) ;
VAN DOESUM, Jaap (University Medical Center Groningen) ;
SILI, Uluhan (Marmara University) ;
Labrador, Jorge (Hospital Universitario de Burgos) ;
Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
BILGIN, Yavuz M. (Admiraal de Ruijter Hospital) ;
WEINBERGEROVÁ, Barbora (Masaryk University) ;
SERRANO, Laura (Hospital Universitario de Cabueñes (Gijón)) ;
RIBERA-SANTA SUSANA, José-María (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
MALAK, Sandra (Institut Curie) ;
LOUREIRO-AMIGO, José (Hospital de Sant Joan Despí Moisès Broggi) ;
GLENTHØJ, Andreas (University of Copenhagen) ;
Cordoba, Raul (Hospital Universitario Fundacion Jimenez Diaz (Madrid)) ;
NUNES-RODRIGUES, Raquel (Instituto Português de Oncologia) ;
GONZÁLEZ-LÓPEZ, Tomás-José (Hospital Universitario de Burgos) ;
KARLSSON, Linda Katharina (Gentofte Hospital) ;
JIMÉNEZ-LORENZO, María-Josefa (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
HERNÁNDEZ-RIVAS, José-Ángel (Hospital Universitario Infanta Leonor) ;
Jakšić, Ozren (Dubrava University Hospital) ;
RÁČIL, Zdeněk (Institute of Hematology and Blood Transfusion (República Txeca)) ;
Busca, Alessandro (AOU Citta' della Salute e della Scienza) ;
Corradini, Paolo (University of Milan) ;
Hoenigl, Martin (University of Graz) ;
KLIMKO, Nikolai (North-Western State Medical University named after Iliá Ilich Méchnikov) ;
KÖHLER, Philipp (University of Cologne) ;
PAGLIUCA, Antonio (King's College Hospital NHS Foundation Trust (Regne Unit)) ;
PASSAMONTI, Francesco (University of Insubria and ASST Sette Laghi) ;
CORNELY, Oliver A. (Partner Site Bonn-Cologne, Cologne) ;
Universitat Autònoma de Barcelona
2021 - 10.1182/blood.2021014124
Blood, november 2021
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
7 p, 820.3 KB |
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
/
Stein, A. S. (Gehr Family Center for Leukemia Research. City of Hope) ;
Kantarjian, H. (The University of Texas M.D. Anderson Cancer Center) ;
Gökbuget, N. (Department of Medicine II. Goethe University) ;
Bargou, R. C. (Comprehensive Cancer Center Mainfranken. University Hospital Würzburg) ;
Litzow, M. R. (Mayo Clinic) ;
Rambaldi, Alessandro (Department of Oncology and Hemato-Oncology. University of Milan and Azienda Pope John XXIII Hospital) ;
Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Zhang, A. (Amgen Inc.) ;
Zimmerman, Z. (Amgen Inc.) ;
Zugmaier, Gerhard (Amgen Research Munich) ;
Topp, M. S. (Medical Clinic and Polyclinic II. University Hospital Würzburg) ;
Universitat Autònoma de Barcelona
Patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) following allogeneic hematopoietic stem cell transplantation (alloHSCT) have a poor prognosis, and alternative therapies are needed for this patient population. [...]
2019 - 10.1016/j.bbmt.2019.04.010
Biology of Blood and Marrow Transplantation, Vol. 25 Núm. 8 (august 2019) , p. 1498-1504
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
